Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





SARS-CoV-2 Viral Load Could Be Key to Recovery from COVID-19

By HospiMedica International staff writers
Posted on 28 Sep 2020
A new study has shown that the initial SARS-CoV-2 viral load in nasopharyngeal samples has been decreasing as the pandemic progressed and the decline in viral load was associated with a decrease in death rate.

The dynamics of the SARS-CoV-2 viral load (VL) on a population level remain poorly characterised. More...
In a new study presented at the ESCMID Conference on Coronavirus Disease (ECCMID, online 23-25 September), the researchers presented data describing the downward trend in the initial SARS-CoV-2 VL in nasopharyngeal swab samples of patients hospitalized at the Detroit Medical Center (Detroit, MI, USA) during the period of April 4- June 5, 2020. They conducted a retrospective study that included all hospitalized patients who had initial nasopharyngeal swab samples analyzed that returned positive for SARS-CoV-2 by PCR testing during the period. To estimate the viral load, the authors used the so-called cycle threshold (Ct) value provided by the test for each sample - a higher Ct indicates a lower viral load. Based on their studies, the authors designated high, intermediate, and low VL samples to have a Ct value of 25 or under, 26-36, and 37 or over, respectively.

During the first week of the study (week of April 4, 2020), 49% of the initial VL samples were in the intermediate group, compared to 25.5% each in the low and high VL categories respectively. Thereafter, there was a progressive decline in the percentage of samples in the high and intermediate VL categories with a concomitant rise in the percentage of samples in the low VL category. By week five of the study, 70% of the positive samples had an initial low VL. This trend in initial VL coincided with a decrease in the percent of deaths. Almost half of the patients in the high VL group died (45%) compared to 32% and 14 % of the intermediate and low VL categories, respectively.

"During the April-June 2020 period of the COVID-19 pandemic, the initial SARS-CoV-2 load steadily declined among hospitalized patients with a corresponding decrease in the percent of deaths over time. Though confounding variables have not been evaluated, this suggests an association between initial viral load and mortality," concluded the authors.

"Exact reasons for a decrease in initial viral load over time are unclear. A downward trend in the initial VL may reflect a reduction in the severity of the pandemic and trends in the viral load values over time may represent a marker to assess the progress of the pandemic,” said Dr. Said El Zein, Wayne State University/ Detroit Medical Center. "Rapid implementation of social distancing measures, lockdown and widespread use of facemasks may have contributed to a decrease in the exposure to the virus."

Related Links:
Detroit Medical Center


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.